News Snapshot:
JW (Cayman) Therapeutics has launched pre-deal investor education for its Hong Kong IPO, setting the final stage of the deal ahead of launch in motion. The Chinese biotechnology company began three days of pre-marketing on Monday, drumming up interest for its listing, according to a source familiar with the matter. Goldman Sachs and UBS are the IPO sponsors. They are also global co-ordinators with CICC and CLSA. ICBC International, Mirae Asset Securities and
